Market Cap : 394.37 M | Enterprise Value : 367.09 M | PE Ratio : 15.51 | PB Ratio : 7.83 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Co-Diagnostics's other operating expense for the three months ended in Sep. 2020 was $0.03 Mil. Its other operating expense for the trailing twelve months (TTM) ended in Sep. 2020 was $0.10 Mil.
Co-Diagnostics's quarterly other operating expense increased from Mar. 2020 ($0.02 Mil) to Jun. 2020 ($0.03 Mil) and increased from Jun. 2020 ($0.03 Mil) to Sep. 2020 ($0.03 Mil).
Co-Diagnostics's annual other operating expense increased from Dec. 2017 ($0.04 Mil) to Dec. 2018 ($0.05 Mil) and increased from Dec. 2018 ($0.05 Mil) to Dec. 2019 ($0.07 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expenses" section.
Other operating expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of other operating expenses which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2020 was 0.018 (Dec. 2019 ) + 0.021 (Mar. 2020 ) + 0.026000000000001 (Jun. 2020 ) + 0.035 (Sep. 2020 ) = $0.10 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline